FDA Approved: PALIPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal's supplemental application for a generic paliperidone product, expanding access to treatment for schizophrenia and schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• PALIPERIDONE (paliperidone)

Snippet

SUPPL AP for PALIPERIDONE (PALIPERIDONE)